You searched for "Blepharoptosis"

90 results found

Oral azithromycin for meibomian gland disease

Oral tetracyclines have been the traditional systemic treatment of blepharitis and acne rosacea, through inhibiting bacterial lipase production and reducing fatty acids. However, tetracyclines have a number of adverse side-effects and are required to be taken for a long duration...

Oct/Nov 2016 Quiz

History A 67-year-old female patient had chronic left canaliculitis becoming painful and more recently complicated by left lower blepharitis. Examination revealed a small fleshy lump on the medial aspect of the left lower eyelid. There was also swelling of the...

Long-term meibomian gland function following a single thermal pulsation treatment

Dry eyes secondary to blepharitis and or meibomian gland dysfunction, though extremely common, is an annoyingly difficult condition to treat for several patients. Part of this difficulty lies in the inability of most patients to follow intensive and often times...

New cataract, cornea and ocular surface disease innovations from Kestrel Ophthalmics

Kestrel Ophthalmics, (a Cutting Edge company) is pleased to introduce an integrated medical and surgical approach to treat a range of conditions.

Altacor add new products to the trusted Clinitas® brand family

Altacor are pleased to announce the launch of two new products. The range has now been expanded to include 0.2% preservative free sodium hyaluronate options to treat mild to moderate dry eye, sitting alongside our existing Clinitas 0.4% products for treating moderate to severe dry eye.

Scope unveils newly rebranded VitA-POS as HYLO NIGHT® with all of the same features and benefits, but now under the trusted HYLO brand of ocular lubricants

SCOPE is pleased to announce the launch of its new night-time dry eye ointment HYLO-NIGHT® (formerly VitA-POS).

Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.

This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.

2018 update on intravitreal injections

In this review article the authors have highlighted the standardised and structured approach to intravitreal injections (IVI) by examining the recent evidence-based literature. IVI is the most commonly performed procedure worldwide with low potential risk of endophthalmitis. IOP spikes are...

If looks could kill – kohl and the eye

Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: If looks could kill – kohl and the eye Human fascination with beautification can be traced...

Viva Las Vegas: Dr Corey Hochman

Speaking with Phoenix-based ophthalmologist and poker player, Dr Corey Hochman, Peter Cackett explores the themes of success and failure, and how the ups and downs of one’s ambition can provide an overwhelming gratitude for life. “Money won is twice as...

Oculogyric crisis with B12 deficiency

An oculogyric crisis (OGC) is a dystonic movement disorder of the eyes which can last from seconds to hours. Although there is no published diagnostic criteria for OGC, typically the onset is acute, and it is characterised by conjugate upward...

Photophobia: an unusual symptom of a pituitary macroadenoma

Introduction Photophobia, defined as ‘an abnormal intolerance to light’, is commonly associated with a range of both ocular and neurological pathologies such as dry eye, blepharospasm, corneal pathologies, cataracts, uveitis, retinal dystrophies, optic neuritis, migraine, meningitis, and traumatic brain injury...